UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 41

Sortiert nach

Predictive biomarkers in radioresistant rectal cancer: A systematic review

Critical reviews in oncology/hematology, 2023-06, Vol.186, p.103991-103991, Article 103991

2023

Link zum Volltext

Verfügbarkeit prüfen

TAS-102 with or without bevacizumab in patients with chemorefractory metastatic colorectal cancer: an investigator-initiated, open-label, randomised, phase 2 trial

The lancet oncology, 2020-03, Vol.21 (3), p.412-420

2020

Link zum Volltext

Verfügbarkeit prüfen

Therapy with pembrolizumab in treatment‐naïve patients with nonmetastatic, mismatch repair deficient colorectal cancer

International journal of cancer, 2023-05, Vol.152 (10), p.2145-2152

2023

Link zum Volltext

Verfügbarkeit prüfen

On estimating the time to statistical cure

BMC medical research methodology, 2020-03, Vol.20 (1), p.71-71, Article 71

2020

Link zum Volltext

Verfügbarkeit prüfen

Pre-treatment serum vitamin D deficiency is associated with increased inflammatory biomarkers and short overall survival in patients with pancreatic cancer

European journal of cancer (1990), 2021-02, Vol.144, p.72-80

2021

Link zum Volltext

Verfügbarkeit prüfen

Initial treatment and survival in 4163 Danish patients with pancreatic cancer: A nationwide unselected real-world register study

European journal of cancer (1990), 2020-04, Vol.129, p.50-59

2020

Link zum Volltext

Verfügbarkeit prüfen

Patterns of Palliative Chemotherapy and Survival in Patients With Pancreatic Cancer Focusing on Age: A Nationwide Real-World Danish Registry Study

Pancreas, 2021-05, Vol.50 (5), p.685

2021

Link zum Volltext

Verfügbarkeit prüfen

Trends and drivers of pharmaceutical expenditures from systemic anti-cancer therapy

The European journal of health economics, 2023-08, Vol.24 (6), p.853-865

2023

Link zum Volltext

Verfügbarkeit prüfen

Review on adjuvant chemotherapy for rectal cancer - why do treatment guidelines differ so much?

Acta oncologica, 2015-04, Vol.54 (4), p.437-446

2015

Link zum Volltext

Verfügbarkeit prüfen

Extracting Systemic Anticancer Treatment Lines from the Danish National Patient Registry for Solid Tumour Patients Treated in the North Denmark Region Between 2009 and 2019

Clinical epidemiology, 2024-01, Vol.16, p.165-174

2024

Link zum Volltext

Verfügbarkeit prüfen

A phase II study of daily encorafenib in combination with biweekly cetuximab in patients with BRAF V600E mutated metastatic colorectal cancer: the NEW BEACON study

BMC cancer, 2022-12, Vol.22 (1), p.1321-1321, Article 1321

2022

Link zum Volltext

Verfügbarkeit prüfen

Quality of Life in Vulnerable Older Patients with Metastatic Colorectal Cancer Receiving Palliative Chemotherapy—The Randomized NORDIC9-Study

Cancers, 2021-05, Vol.13 (11), p.2604

2021

Link zum Volltext

Verfügbarkeit prüfen

The effect of nutritional interventions in acute radiation-induced diarrhoea in patients with primary pelvic cancer: A systematic review

Critical reviews in oncology/hematology, 2023-08, Vol.188, p.104038-104038, Article 104038

2023

Link zum Volltext

Verfügbarkeit prüfen

Oxaliplatin causes increased offset analgesia during chemotherapy – a feasibility study

Scandinavian journal of pain, 2023-10, Vol.23 (4), p.729-734

2023

Link zum Volltext

Verfügbarkeit prüfen

Significance of age and comorbidity on treatment modality, treatment adherence, and prognosis in elderly ovarian cancer patients

Gynecologic oncology, 2012-11, Vol.127 (2), p.367-374

2012

Link zum Volltext

Verfügbarkeit prüfen

Outcomes of emergency surgical interventions in right-sided colonic cancer: nationwide population-based study based on Danish Colorectal Cancer Group register

BJS open, 2023-01, Vol.7 (1)

2023

Link zum Volltext

Verfügbarkeit prüfen

Reduced-dose combination chemotherapy (S-1 plus oxaliplatin) versus full-dose monotherapy (S-1) in older vulnerable patients with metastatic colorectal cancer (NORDIC9): a randomised, open-label phase 2 trial

The lancet. Gastroenterology & hepatology, 2019-05, Vol.4 (5), p.376-388

2019

Link zum Volltext

Verfügbarkeit prüfen

Treatment planning for patients with low rectal cancer in a multicenter prospective organ preservation study

Physica medica, 2024-02, Vol.118, p.103206-103206, Article 103206

2024

Link zum Volltext

Verfügbarkeit prüfen

Is the accuracy of preoperative MRI stage in rectal adenocarcinoma influenced by tumour height?

Acta oncologica, 2018-06, Vol.57 (6), p.1-734

2018

Link zum Volltext

Verfügbarkeit prüfen

The effect of postoperative gemcitabine on overall survival in patients with resected pancreatic cancer: A nationwide population-based Danish register study

Acta oncologica, 2019-06, Vol.58 (6), p.864-871

2019

Link zum Volltext

Verfügbarkeit prüfen

The effect of BRAF V600E mutation on survival and treatment efficacy in vulnerable older patients with metastatic colorectal cancer - A post-hoc exploratory analysis of the randomized NORDIC9-study

Journal of geriatric oncology, 2024-03, Vol.15 (2), p.101632

2024

Link zum Volltext

Verfügbarkeit prüfen

Prognostic value of baseline functional status measures and geriatric screening in vulnerable older patients with metastatic colorectal cancer receiving palliative chemotherapy – The randomized NORDIC9-study

Journal of geriatric oncology, 2023-01, Vol.14 (1), p.101408-101408, Article 101408

2023

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 41

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(40)
Mit Volltextzugriff
(39)

Publikationsform

Artikel
(40)
Tagungsberichte
(1)

Sprache

Englisch
(41)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Predictive biomarkers in radioresistant rectal cancer: A systematic review

TAS-102 with or without bevacizumab in patients with chemorefractory metastatic colorectal cancer: an investigator-initiated, open-label, randomised, phase 2 trial

Therapy with pembrolizumab in treatment‐naïve patients with nonmetastatic, mismatch repair deficient colorectal cancer

On estimating the time to statistical cure

Pre-treatment serum vitamin D deficiency is associated with increased inflammatory biomarkers and short overall survival in patients with pancreatic cancer

Initial treatment and survival in 4163 Danish patients with pancreatic cancer: A nationwide unselected real-world register study

Feasibility and early clinical impact of precision medicine for late-stage cancer patients in a regional public academic hospital

Patterns of Palliative Chemotherapy and Survival in Patients With Pancreatic Cancer Focusing on Age: A Nationwide Real-World Danish Registry Study

Trends and drivers of pharmaceutical expenditures from systemic anti-cancer therapy

Review on adjuvant chemotherapy for rectal cancer - why do treatment guidelines differ so much?

Extracting Systemic Anticancer Treatment Lines from the Danish National Patient Registry for Solid Tumour Patients Treated in the North Denmark Region Between 2009 and 2019

A phase II study of daily encorafenib in combination with biweekly cetuximab in patients with BRAF V600E mutated metastatic colorectal cancer: the NEW BEACON study

Quality of Life in Vulnerable Older Patients with Metastatic Colorectal Cancer Receiving Palliative Chemotherapy—The Randomized NORDIC9-Study

The effect of nutritional interventions in acute radiation-induced diarrhoea in patients with primary pelvic cancer: A systematic review

Response to the letter entitled: Re: Pre-treatment serum vitamin D deficiency is associated with increased inflammatory biomarkers and short overall survival in patients with pancreatic cancer: Analysis of the prognostic effect of serum vitamin D on pancreatic cancer: Several confounders

Oxaliplatin causes increased offset analgesia during chemotherapy – a feasibility study

Significance of age and comorbidity on treatment modality, treatment adherence, and prognosis in elderly ovarian cancer patients

Outcomes of emergency surgical interventions in right-sided colonic cancer: nationwide population-based study based on Danish Colorectal Cancer Group register

Reduced-dose combination chemotherapy (S-1 plus oxaliplatin) versus full-dose monotherapy (S-1) in older vulnerable patients with metastatic colorectal cancer (NORDIC9): a randomised, open-label phase 2 trial

Treatment planning for patients with low rectal cancer in a multicenter prospective organ preservation study

Is the accuracy of preoperative MRI stage in rectal adenocarcinoma influenced by tumour height?

The effect of postoperative gemcitabine on overall survival in patients with resected pancreatic cancer: A nationwide population-based Danish register study

The effect of BRAF V600E mutation on survival and treatment efficacy in vulnerable older patients with metastatic colorectal cancer - A post-hoc exploratory analysis of the randomized NORDIC9-study

The Prognostic Value of Pre-Treatment Circulating Biomarkers of Systemic Inflammation (CRP, dNLR, YKL-40, and IL-6) in Vulnerable Older Patients with Metastatic Colorectal Cancer Receiving Palliative Chemotherapy-The Randomized NORDIC9-Study

Prognostic value of baseline functional status measures and geriatric screening in vulnerable older patients with metastatic colorectal cancer receiving palliative chemotherapy – The randomized NORDIC9-study

Suchergebnisse filtern